diazooxonorleucine has been researched along with Experimental Mammary Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| STOCK, CC; TARNOWSKI, GS | 1 |
| Catane, R; Houchens, DP; Muggia, FM; Ovejera, AA; Sheridan, MA | 1 |
2 other study(ies) available for diazooxonorleucine and Experimental Mammary Neoplasms
| Article | Year |
|---|---|
Effects of combinations of azaserine and of 6-diazo-5-oxo-L-norleucine with purine analogs and other antimetabolites on the growth of two mouse mammary carcinomas.
Topics: Animals; Antimetabolites; Antineoplastic Agents; Azaserine; Breast; Breast Neoplasms; Diazooxonorleucine; Humans; Leucine; Mammary Neoplasms, Experimental; Purines; Serine | 1957 |
Efficacy of 6-diazo-5-oxo-L-norleucine and N-[N-gamma-glutamyl-6-diazo-5-oxo-norleucinyl]-6-diazo-5-oxo-norleucine against experimental tumors in conventional and nude mice.
Topics: Animals; Azo Compounds; Colonic Neoplasms; Diazooxonorleucine; Drug Evaluation, Preclinical; Female; Humans; Leukemia, Experimental; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred Strains; Mice, Nude; Neoplasm Transplantation; Neoplasms, Experimental; Transplantation, Heterologous | 1979 |